Top Buy
| Wertpapier | Buy | Sell | Buy (1M) | Sell (1M) | Kurs | Kursziel ▼ | Potential |
|---|---|---|---|---|---|---|---|
| Edwards Lifesciences Corp. | 27 | 1 | 1 | 0 | 81,59 € | 88,17 € | 8,06 % |
| Merit Medical Systems | 17 | 0 | 0 | 0 | 76,00 € | 86,90 € | 14,34 % |
| Ultragenyx Pharmaceutical Inc. | 22 | 1 | 6 | 0 | 36,40 € | 85,51 € | 134,92 % |
| Gilead Sciences Inc | 11 | 1 | 0 | 0 | 60,35 € | 84,81 € | 40,53 % |
| Hologic Inc. | 17 | 0 | 0 | 0 | 67,50 € | 84,52 € | 25,22 % |
| Cytokinetics Inc. | 32 | 1 | 6 | 0 | 49,80 € | 83,21 € | 67,08 % |
| Centene Corp. | 16 | 0 | 1 | 0 | 64,02 € | 82,76 € | 29,28 % |
| Lantheus Holdings Inc | 2 | 0 | 0 | 0 | 74,62 € | 80,00 € | 7,21 % |
| Intra-Cellular Therapies Inc. | 27 | 0 | 3 | 0 | 63,50 € | 79,55 € | 25,28 % |
| Healthequity Inc. | 1 | 0 | 0 | 0 | 77,50 € | 79,00 € | 1,94 % |
| Incyte Corp. | 12 | 2 | 0 | 0 | 57,72 € | 78,05 € | 35,22 % |
| Bio-Techne Corp. | 10 | 0 | 0 | 0 | 71,00 € | 75,94 € | 6,95 % |
| Boston Scientific | 49 | 0 | 3 | 0 | 72,00 € | 73,88 € | 2,61 % |
| Lemaitre Vascular Inc | 2 | 0 | 0 | 0 | 73,00 € | 73,50 € | 0,68 % |
| Apellis Pharmaceuticals | 3 | 0 | 0 | 0 | 39,23 € | 70,00 € | 78,46 % |
| XOMA Corp. | 7 | 0 | 1 | 0 | 25,20 € | 68,62 € | 172,30 % |
| Axonics Modulation Technologies Inc | 8 | 0 | 0 | 0 | 59,50 € | 66,36 € | 11,53 % |
| Insmed Inc. | 30 | 1 | 12 | 1 | 58,50 € | 63,62 € | 8,75 % |
| Intellia Therapeutics Inc | 14 | 1 | 1 | 0 | 23,67 € | 60,13 € | 154,04 % |
| Celldex Therapeutics | 13 | 1 | 2 | 0 | 32,40 € | 56,62 € | 74,74 % |
| Catalent Inc. | 1 | 0 | 0 | 0 | 51,78 € | 55,00 € | 6,22 % |
| Arrowhead Pharmaceuticals Inc. | 17 | 2 | 3 | 0 | 24,00 € | 54,74 € | 128,10 % |
| Radnet Inc. | 9 | 3 | 0 | 0 | 55,00 € | 54,58 € | -0,76 % |
| Corbus Pharmaceuticals Holding Inc. | 2 | 1 | 0 | 0 | 45,80 € | 50,00 € | 9,17 % |
| Halozyme Therapeutics Inc. | 18 | 0 | 4 | 0 | 46,58 € | 49,59 € | 6,45 % |